Evolve 7-Year review

It depends on how you weigh the income rider against the carrier. For someone whose main goal is a guaranteed lifetime income stream and who is comfortable with a B-rated carrier, the rider design is genuinely good and the roll-up is competitive. For someone who treats financial-strength rating as a hard requirement — and many income buyers reasonably do, because they're counting on payments 20 or 30 years out — the carrier rating alone may take it off the table regardless of how the rider reads on paper.

The main reason to buy Evolve 7-Year is to set up future protected lifetime income while keeping principal safe from market losses along the way. The income rider is built in, so you don't have to elect or shop for a separate benefit, and the 6% compounded roll-up gives the income base a clear, contractual growth path while you defer. The secondary reason is the included care features — nursing home, terminal illness, and home health care benefits at no added charge, plus a wellness withdrawal that can double your payout for up to five years if you qualify. Those are real value-adds for someone planning around health risk.

I think this annuity is best for someone in the pre-retirement or early-retirement window who wants to use long-term money to build future income, expects to defer withdrawals for several years to let the roll-up work, and has decided the carrier's B rating is an acceptable tradeoff for the rider terms. It fits qualified and non-qualified money equally, since RMDs are accommodated from year one. It is a poor fit for someone who treats financial strength as non-negotiable, anyone who might need meaningful liquidity in the first few years, or a buyer chasing pure accumulation — the growth side is built to support the income guarantee, not to maximize cash value.

You are not buying stock-market upside, and you are not really buying the account value either. You are buying a contractual promise to pay you income for life, supported by an income base that grows at 6% compounded whether or not the index strategies earn anything. That distinction is the heart of this product. The account value, the index strategies, and the 3% premium bonus are all secondary to the income base, which is the figure your lifetime withdrawals are calculated from. It's important to understand that the income base is a phantom accounting figure used to size your withdrawals — it is not a lump sum you can walk away with. If you surrender the contract or pass away, you get the account value, not the income base.

The Enhanced Lifetime Withdrawal Benefit is built into Evolve 7-Year — there's no separate rider to add. Before you turn income on, the income base grows at a **6% compounded rate for up to 20 years**, then continues at a guaranteed 3% in years 21 through 30, for a maximum 30-year roll-up window. When you activate income, your age determines the withdrawal percentage, and that percentage applied to the income base sets your guaranteed annual payment for life — payments continue even if the account value eventually runs to zero. The cost of the rider is a **1.50% annual spread applied to the account value**, and importantly that spread is capped at the interest credited for the year, so the rider charge can't drive the account value down on its own in a flat or negative year. Two included enhancements matter here: the care benefits (nursing home, terminal illness, home health care) come at no extra charge, and after a two-year wait the Wellness Withdrawal can pay 2x the single (or 1.5x the joint) lifetime amount for up to five years if you qualify.

The most-discussed secondary feature is the 3% premium bonus, and it's worth being precise about what it is and isn't. This is an **account-value bonus**, not an income-base bonus — it's credited to your cash value on first-year premium. But it vests slowly: 0% in year one, just 0.15% in year two, and it doesn't reach the full 3% until year eight or later. So while the headline reads "3% bonus," you don't actually own all of it until well past the surrender period, and if you surrender early you forfeit the unvested portion through the Interest & Bonus Recovery provision. In practical terms the bonus is a modest sweetener to the cash value, not a meaningful boost to your income — the income base grows on the 6% roll-up regardless of the bonus. The index strategies (12 indexed plus a 4.50% fixed account, with caps, spreads, and participation rates up to 200% on select strategies) are the other supporting feature, but on an income-first contract they're there to support the guarantee rather than to drive growth.

This is a long-term income contract, not a source of accessible cash, and the surrender schedule makes that clear: it starts at a steep **12%** and stays in double digits through year three. After the first year you can take one free withdrawal of up to 5% of account value per year without charge, MVA, or bonus recovery, and RMDs are available even in year one. Anything above the free amount during the surrender period is hit by three things at once — the withdrawal charge, a Market Value Adjustment (MVA, which means your surrender cost moves with interest rates and can rise if rates have climbed), and the Interest & Bonus Recovery, which claws back credited interest and unvested bonus on a declining schedule (100% in year one down to 25% in year seven). The takeaway is blunt: outside the 5% free amount and RMDs, this contract is not money you should plan to touch for seven years.

There is no explicit base-contract fee. The fee that matters is the income rider's **1.50% annual spread on account value**, which buys you the 6% compounded roll-up and the lifetime guarantee. Because that spread is capped at the year's interest credit, it can't push your account value below where it started in a bad year — a buyer-friendly detail. The real tradeoffs here aren't fee-line items, they're structural: the index strategies are built to fund an income guarantee, not to maximize growth; the premium bonus vests so slowly that it's largely theoretical for anyone who might surrender early; and the surrender plus MVA plus bonus-recovery stack makes early exits expensive. The biggest non-fee tradeoff sits in the Carrier Snapshot — a lifetime income promise from a B-rated carrier carries more counterparty risk than the same promise from an A-rated one, and that's the cost that doesn't show up on a rate sheet.

Legal Entity: SILAC Insurance Company

AM Best Rating: B